Guidelines for clinical trials using artificial intelligence - SPIRIT-AI and CONSORT-AI†
- PMID: 33016344
- DOI: 10.1002/path.5565
Guidelines for clinical trials using artificial intelligence - SPIRIT-AI and CONSORT-AI†
Abstract
The rapidly growing use of artificial intelligence in pathology presents a challenge in terms of study reporting and methodology. The existing guidelines for the design (SPIRIT) and reporting (CONSORT) of clinical trials have been extended with the aim of ensuring production of the highest quality evidence in this field. We explore these new guidelines and their relevance and application to pathology as a specialty. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
Keywords: CONSORT-AI; SPIRIT-AI; artificial intelligence; checklist; clinical trial; digital pathology; machine learning; pathology; randomised trial; reporting guidelines.
© 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
References
-
- Shrestha A, Mahmood A. Review of deep learning algorithms and architectures. IEEE Access 2019; 7: 53040-53065.
-
- Silver D, Huang A, Maddison CJ, et al. Mastering the game of go with deep neural networks and tree search. Nature 2016; 529: 484-489.
-
- Mnih V, Kavukcuoglu K, Silver D, et al. Playing Atari with deep reinforcement learning. arXiv: 1312.5602 [cs:LG]; December 2013.
-
- Salto-Tellez M, Maxwell P, Hamilton P. Artificial intelligence - the third revolution in pathology. Histopathology 2019; 74: 372-376.
-
- Bejnordi BE, Veta M, van Diest P, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA 2017; 318: 2199-2210.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources

